Tag: Obesity
Semaglutide Beneficial for Hidradenitis Suppurativa in Patients With Obesity
Semaglutide added to standard treatments yields improvement in quality of life, reduction in flares
Prevalence of Obesity 40.3 Percent in U.S. From August 2021 to August 2023
No significant change in prevalence of obesity seen from 2013-2014 to August 2021-2023, but prevalence of severe obesity increased
BMI Outside of Normal Category Linked to Lower Fecundability
Increased odds of subfertility seen in association with underweight, overweight, obesity in women and obesity in men
Guidance Provided for Management of Obesity in Kidney Disease
Effective obesity management remains challenging and requires a multidisciplinary team and combination of interventions
Excess Body Weight Linked to Increased Risk for Second Primary Neoplasm
Risk for any second primary cancer increased among those with overweight and obesity compared with those with normal weight
At Least One in Five People Has Obesity in Each U.S. State
CDC data show that in 23 states, 35 percent or more of the population is now obese
Abdominal Adipose Tissue Linked to Musculoskeletal Pain
In both men and women, higher levels of adipose tissue were associated with increased odds of reporting chronic pain
Weight-Loss Surgery Benefits Blood Pressure Management
Benefits include remission and control of hypertension while cutting dependence on antihypertensive medications
Interleukin-6 May Boost Prediction of Obesity-Related Cancers
Findings seen among patients with newly diagnosed type 2 diabetes
Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure
MACE, heart failure composite end point, cardiovascular death, and all-cause death all improved with semaglutide for patients with versus without heart failure
